Virtus Investment Advisers, LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 19481 HARTFORD, CT

Position in AUPH

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,247,413

+$457,997 QoQ

Shares Held

73,507

+38.0% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#89

of 279 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $130,556,170 across 185 Biotechnology names. AUPH ranks #43 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,544	$3,349,107
2	ALNY	Alnylam Pharmaceuticals, Inc.	9,953	$2,996,151
3	REGN	Regeneron Pharmaceuticals, Inc.	4,320	$2,693,692
4	MRNA	Moderna, Inc.	23,300	$1,631,699
5	RARE	Ultragenyx Pharmaceutical Inc.	47,757	$1,594,606
6	PGEN	Precigen, Inc.	261,322	$1,489,535
7	AGIO	Agios Pharmaceuticals, Inc.	39,473	$1,464,843
8	RYTM	Rhythm Pharmaceuticals, Inc.	13,158	$1,460,932

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,247,413	73,507	+38.0%	Shares	Other	2026-08-11
2026-03-31	$789,416	53,267	+23.5%	Shares	Other	2026-05-14
2025-12-31	$687,716	43,117	-20.1%	Shares	Other	2026-02-17
2025-09-30	$596,666	53,997	0.0%	Shares	Other	2025-11-14
2025-06-30	$457,354	53,997	+45.7%	Shares	Other	2025-08-13
2025-03-31	$297,890	37,051	-55.3%	Shares	Other	2025-05-15
2024-12-31	$743,795	82,828	0.0%	Shares	Other	2025-02-14
2024-09-30	$607,129	82,828	0.0%	Shares	Other	2024-11-14
2024-06-30	$472,947	82,828	—	Shares	Other	2024-08-14
No filing history on record for this holder in this stock.